Home
Contact
Links
PsiOxus Therapeutics
/
Links
Comments are closed.
PsiOxus in the News
PsiOxus Upcoming Events
PsiOxus Awards & Achievements
Recent Posts
PsiOxus to Present Positive Biomarker Data at ESMO 2021 Demonstrating the Potential of Their Novel Tumor-Selective T SIGn® vector, NG-350A, to Re-Engineer Advanced Cancers
PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastases
PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration
Priya Mande, PsiOxus COO, listed in the Top 25 Women Leaders in Biotechnology for 2020
PsiOxus Therapeutics Announces Clinical Trial with Third Cancer Gene Therapy Treatment and Appointment of New Chief Medical Officer
Filter Publications
Enadenotucirev Preclinical
Enadenotucirev Clinical
T-SIGn
Reviews
© Copyright 2022 PsiOxus Therapeutics
RSS
Back to Top
About
Vision & Strategy
Our People
T-SIGn Platform Technology
Pipeline
Publications and Posters
Partners and Investors
News and Events
Careers
Contact Us
Menu
Comments are closed.